Phio Pharmaceuticals Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · King Of Prussia, PA
PHIO chart
What traders are saying about $PHIO
Latest postsPhio Pharmaceuticals Corp. news
- Phio Pharmaceuticals Corp. Estimates – NASDAQ:PHIO
TradingView ·
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Yahoo Finance ·
- Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance
Yahoo Finance ·
- OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand
Yahoo Finance ·
- Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
Yahoo Finance ·
- OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
Yahoo Finance ·
- Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
Yahoo Finance ·
- Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference
Yahoo Finance ·
- Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
Yahoo Finance ·
- Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
Yahoo Finance ·
- Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Yahoo Finance ·
Phio Pharmaceuticals Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.7M | -$7.2M | -$10.8M | -$11.5M |
| Diluted EPS | – | $-9.08 | $-46.76 | $-10.10 |
| Total assets (year end) | $21.5M | $5.7M | $9.4M | $12.8M |
| Cash and equivalents (year end) | $21.0M | $5.4M | $8.5M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Phio Pharmaceuticals Corp.
- Ticker
- PHIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- King Of Prussia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1533040
- Former names
- RXi Pharmaceuticals Corp
Frequently asked questions
What exchange is Phio Pharmaceuticals Corp. listed on?
Phio Pharmaceuticals Corp. trades on the Nasdaq under the ticker symbol PHIO.
What industry is Phio Pharmaceuticals Corp. in?
Phio Pharmaceuticals Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Phio Pharmaceuticals Corp. headquartered?
Phio Pharmaceuticals Corp.'s business address on file with the SEC is in King Of Prussia, PA.
When does Phio Pharmaceuticals Corp.'s fiscal year end?
Phio Pharmaceuticals Corp.'s fiscal year ends on December 31.
How much revenue did Phio Pharmaceuticals Corp. report?
Phio Pharmaceuticals Corp. reported $0 in revenue for calendar year 2020, according to its SEC filings.